Information  X 
Enter a valid email address

Fed Rep Nigeria (78UT)

  Print      Mail a friend

Wednesday 29 March, 2017

Fed Rep Nigeria

Publication of Prospectus Supplement

RNS Number : 9340A
Federal Republic of Nigeria (The)
29 March 2017
 

Publication of Prospectus Supplement

The following prospectus supplement has been approved by the UK Financial Conduct Authority and is available for viewing:

Prospectus supplement dated 29 March 2017 (the "Prospectus Supplement") relating to the U.S.$1,500,000,000 (increased from U.S.$1,000,000,000) Global Medium Term Note Programme (the "Programme") of the Federal Republic of Nigeria (the "Issuer")

The Prospectus Supplement must be read in conjunction with the base prospectus dated 6 February 2017 in respect of the Programme (the "Base Prospectus") for the purposes of the Prospectus Directive (Directive 2003/71/EC, as amended).

To view the full document, please paste the following URL into the address bar of your browser.

http://www.rns-pdf.londonstockexchange.com/rns/9340A_-2017-3-29.pdf

For further information, please contact: [email protected]


DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Prospectus Supplement and the Base Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus Supplement and/or Base Prospectus is not addressed.  Prior to relying on the information contained in the Prospectus Supplement and/or Base Prospectus you must ascertain from the Prospectus Supplement and the Base Prospectus whether or not you are part of the intended addressees of the information contained therein. 

In particular, the Prospectus Supplement does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States or in any other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration, exemption from registration or qualification under the securities law of any such jurisdiction.  The securities referred to in the Prospectus Supplement have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act") and may not be offered or sold in the United States absent registration or an exemption from registration under the Securities Act, and the rules and regulations thereunder.  The Issuer does not intend to register any of the securities referred to in the Prospectus Supplement in the United States or to conduct a public offering of the securities referred to in the Prospectus Supplement in the United States or elsewhere.

Your right to access this service is conditional upon complying with the above requirement.

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PSPUKUVRBSAOUAR

a d v e r t i s e m e n t